Hong Kong Journal of Nephrology
Volume 8, Issue 1 , Pages 5-9 , April 2006

Use of MARS in Hepatorenal Syndrome — A Local Perspective

  • Alexander Chiu

      Affiliations

    • Intensive Care Unit, Queen Mary Hospital, The University of Hong Kong, Pokfulam, Hong Kong SAR, China
    • ,
  • Sheung Tat Fan

      Affiliations

    • Centre for the Study of Liver Disease and Department of Surgery, The University of Hong Kong, Pokfulam, Hong Kong SAR, China
    • Intensive Care Unit, Queen Mary Hospital, The University of Hong Kong, Pokfulam, Hong Kong SAR, China
    • Corresponding Author InformationAddress correspondence and reprint requests to: Professor Sheung Tat Fan, Department of Surgery, The University of Hong Kong, Queen Mary Hospital, 102 Pokfulam Road, Hong Kong SAR, China. Fax: (+852) 2818-4407

References 

  1. Gines A , Escorsell A , Gines P , Salo J , Jimenez W , Inglada L , et al.   Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites . Gastroenterology . 1993;105:229–236
  2. Hecker R , Sherlock S . Electrolyte and circulatory changes in terminal liver failure . Lancet . 1956;271:1121–1125
  3. Koppel MH , Coburn JW , Mims MM , Goldstein H , Boyle JD , Rubini ME . Transplantation of cadaveric kidneys from patients with hepatorenal syndrome. Evidence for the functional nature of renal failure in advanced liver disease . N Engl J Med . 1969;280:1367–1371
  4. Arroyo V , Gines P , Gerses AL , Dudley FJ , Gentislini P , Laffi G , et al.   Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis . Hepatology . 1996;23:164–176
  5. Guevara M , Gines P , Fernandez-Esparrach G , Sort P , Salmeron JM , Jimenez W , et al.   Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion . Hepatology . 1998;27:35–41
  6. Gulberg V , Bilzer M , Gerbes AL . Long-term therapy and retreatment of hepatorenal syndrome type 1 with ornipressin and dopamine . Hepatology . 1999;30:870–875
  7. Uriz J , Gines P , Cardenas A , Sort P , Jimenez W , Salmeron JM , et al.   Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome . J Hepatol . 2000;33:43–48
  8. Guevara M , Gines P , Bandi JC , Gilabert R , Sort P , Jimenez W , et al.   Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems . Hepatology . 1998;28:416–422
  9. Witzke O , Baumann M , Patschan D , Patschan S , Mitchell A , Treichel U , et al.   Which patients benefit from hemodialysis therapy in hepatorenal syndrome? . J Gastroenterol Hepatol . 2004;19:1369–1373
  10. Stange J , Mitzner S , Ramlow W , Gliesche T , Hickstein H , Schmidt R . A new procedure for the removal of protein bound drugs and toxins . ASAIO J . 1993;39:M621–M625
  11. Stange J , Mitzner S . A carrier-mediated transport of toxins in a hybrid membrane. Safety barrier between a patient's blood and a bioartificial liver . Int J Artif Organs . 1996;19:677–691
  12. Evenepoel P , Maes B , Wilmer A , Nevens F , Fevery J , Kuypers D , et al.   Detoxifying capacity and kinetics of the molecular adsorbent recycling system. Contribution of the different inbuilt filters . Blood Purif . 2003;21:244–252
  13. Auth MK , Kim HS , Beste M , Bonzel KE , Baumann U , Ballauff A , et al.   Removal of metabolites, cytokines and hepatic growth factors by extracorporeal liver support in children . J Pediatr Gastroenterol Nutr . 2005;40:54–59
  14. Sen S , Davies NA , Mookerjee RP , Cheshire LM , Hodges SJ , Williams R , et al.   Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure: a randomized controlled study . Liver Transpl . 2004;10:1109–1119
  15. Mitzner SR , Stange J , Klammt S , Risler T , Erley CM , Bader BD , et al.   Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial . Liver Transpl . 2000;6:277–286
  16. Stange J , Mitzner SR , Risler T , Erley CM , Lauchart W , Goehl H , et al.   Molecular adsorbent recycling system (MARS): clinical results of a new membrane-based blood purification system for bioartificial liver support . Artif Organs . 1999;23:319–330
  17. Stange J , Mitzner SR , Klammt S , Freytag J , Peszynski P , Loock J , et al.   Liver support by extracorporeal blood purification: a clinical observation . Liver Transpl . 2000;6:603–613
  18. Heemann U , Treichel U , Loock J , Philipp T , Gerken G , Malago M , et al.   Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study . Hepatology . 2002;36:949–958
  19. Jalan R , Sen S , Steiner C , Kapoor D , Alisa A , Williams R . Extra-corporeal liver support with molecular adsorbents recirculating system in patients with severe acute alcoholic hepatitis . J Hepatol . 2003;38:24–31
  20. Di Campli C , Santoro MC , Gaspari R , Merra G , Zileri Dal Verme L , Zocco MA , et al.   Catholic university experience with molecular adsorbent recycling system in patients with severe liver failure . Transplant Proc . 2005;37:2547–2550
  21. Lahdenpera A , Koivusalo AM , Vakkuri A , Hockerstedt K , Isoniemi H . Value of albumin dialysis therapy in severe liver insufficiency . Transpl Int . 2005;17:717–723
  22. Koivusalo AM , Vakkuri A , Hockerstedt K , Isoniemi H . Experience of Mars therapy with and without transplantation in 101 patients with liver insufficiency . Transplant Proc . 2005;37:3315–3317
  23. Epstein M . Hepatorenal syndrome. . In:  Epstein M editors. The Kidney in Liver Disease . 4th edition.. Philadelphia: Hanley & Belfus; 1996;p. 75–108
  24. Mitzner SR , Klammt S , Peszynski P , Hickstein H , Korten G , Stange J , et al.   Improvement of multiple organ functions in hepato-renal syndrome during albumin dialysis with the molecular adsorbent recirculating system . Ther Apher . 2001;5:417–422
  25. Palmer RMJ , Ashton DS , Moncada S . Vascular endothelial cells synthesize nitric oxide from L-arginine . Nature . 1988;333:664–666
  26. Martin PY , Gines P , Schrier RW . Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis . N Engl J Med . 1998;339:533–541
  27. Rose C , Felipo V . Limited capacity for ammonia removal by brain in chronic liver failure: potential role of nitric oxide . Metab Brain Dis . 2005;20:275–283
  28. Di Campli C , Zocco MA , Gaspari R , Novi M , Candelli M , Santoliquido A , et al.   The decrease in cytokine concentration during albumin dialysis correlates with the prognosis of patients with acute on chronic liver failure . Transplant Proc . 2005;37:2551–2553
  29. Chiu A , Chan LM , Fan ST . MARS treatment for patients with liver failure - the Hong Kong experience . Liver Int . 2006; (in press).
  30. Gonwa TA , Morris CA , Goldstein RM , Husberg BS , Klintmalm GB . Long-term survival and renal function following liver transplantation in patients with and without hepatorenal syndrome-experience in 300 patients . Transplantation . 1991;51:428–430
  31. Gonwa TA , Klintmalm GB , Levy M , Jennings LS , Goldstein RM , Husberg BS . Impact of pretransplant renal function on survival after liver transplantation . Transplantation . 1995;59:361–365
  32. Lerut J , Goffette P , Laterre PF , Donataccio M , Reynaert MS , Otte JB . Sequential treatment of hepatorenal syndrome and posthepatic cirrhosis by intrahepatic portosystemic shunt (TIPSS) and liver transplantation . Hepatogastroenterology . 1995;42:985–987
  33. Nair S , Verma S , Thuluvath PJ . Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation . Hepatology . 2002;35:1179–1185
  34. Choi JY , Bae SH , Yoon SK , Cho SH , Yang JM , Han JY , et al.   Preconditioning by extracorporeal liver support (MARS) of patients with cirrhosis and severe liver failure evaluated for living donor liver transplantation-a pilot study . Liver Int . 2005;25:740–745

PII: S1561-5413(09)60223-4

doi: 10.1016/S1561-5413(09)60223-4

Hong Kong Journal of Nephrology
Volume 8, Issue 1 , Pages 5-9 , April 2006

Article Tools